Sunitinib (Capsule) 37.5mg

Sunitinib 37.5mg capsules are an oral prescription medicine used for certain types of cancer treatment. It belongs to a class of drugs known as kinase inhibitors. Always follow healthcare provider guidance when using this medication.

Strength

37.5mg

Manufacturer / TM Owner

Sandoz Pty Ltd.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Sunitinib 37.5mg capsules are prescribed to treat specific cancers, including advanced kidney cancer and gastrointestinal stromal tumors. It works by slowing or stopping the growth of cancer cells. Doctors may also use it for other conditions not listed here. Always consult a healthcare professional for personalized advice.

Side Effects

Sunitinib 37.5mg capsules may help manage symptoms related to certain cancers by targeting specific pathways in the body. Common effects include fatigue, digestive changes, or skin reactions. These effects vary by individual and should be monitored by a healthcare provider. Keep track of any new or worsening symptoms.

Precautions & Warnings

Store Sunitinib 37.5mg capsules at room temperature, away from moisture and heat. Keep this medication out of reach of children and pets. Do not use if the packaging is damaged or the capsules appear broken. Always inform your healthcare provider about all medications and supplements you are taking.

Avoid Interactions

Sunitinib 37.5mg capsules may interact with other drugs, including certain antibiotics, antifungals, and herbal supplements. Grapefruit and grapefruit juice can affect how this medication works. Avoid alcohol unless approved by your doctor. Discuss all potential interactions with a healthcare professional before starting treatment.

Frequently Asked Questions

Sunitinib 37.5mg capsules are used to treat advanced kidney cancer and gastrointestinal stromal tumors.

Store at room temperature, away from moisture and heat, and keep out of reach of children.

Always inform your doctor about all medications and supplements to avoid potential interactions.

Common effects may include fatigue, digestive changes, or skin reactions. Report any severe symptoms to your healthcare provider.

Sunitinib is a kinase inhibitor, a type of targeted therapy rather than traditional chemotherapy.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.